Evidence map›Paper›PMID 38083896›Full record

ReviewCurrent pharmaceutical biotechnology2024

An Insight into the Promising Therapeutic Potential of Chicoric Acid.

Ahsas Goyal, Nandini Dubey, Anant Agrawal, Rashmi Sharma, Aanchal Verma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahsas GoyalInstitute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.ORCID 0000-0003-0110-9238
Nandini DubeyInstitute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.ORCID 0000-0003-3758-177X
Anant AgrawalInstitute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
Rashmi SharmaInstitute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
Aanchal VermaInstitute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.ORCID 0000-0002-4250-2282

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmacological treatments that are now recommended for the therapy of chronic illnesses are examined in a great number of studies to determine whether or not they are both safe and effective. Therefore, it is important to investigate various alternative therapeutic assistance, such as natural remedies derived from medicinal plants. In this context, chicoric acid, classified as a hydroxycinnamic acid, has been documented to exhibit a range of health advantages. These include antiviral, antioxidant, anti-inflammatory, obesity-preventing, and neuroprotective effects. Due to its considerable pharmacological properties, chicoric acid has found extensive applications in food, pharmaceuticals, animal husbandry, and various other commercial sectors. This article provides a comprehensive overview of

Indexed as

Caffeic AcidsSuccinatesAnimalsAnti-Inflammatory AgentsAntioxidantsCardiovascular DiseasesDiabetes MellitusHumansAnti-Inflammatory AgentsAntioxidantsCaffeic Acidschicoric acidSuccinatescancerChicoric acidchicoryhydroxycinnamic acidinflammationoxidative stress.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.